FDA approves first-ever RSV vaccine, shots to be available for older adults

Trial data showed the new vaccine, developed by GlaxoSmithKline, was 82% effective at preventing lower respiratory tract illness caused by RSV.

     

from USATODAY - News Top Stories https://ift.tt/69s8xtB
via IFTTT